|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61P 3/06 | (2006.01) | ||
| C07K 16/22 | (2006.01) |
| (11) | Number of the document | 3439689 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17719107.9 |
| Date of filing the European patent application | 2017-04-07 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-13 |
| (46) | Date of publication of the claims translation | 2021-11-10 |
| (86) | Number | PCT/US2017/026679 |
| Date | 2017-04-07 |
| (87) | Number | WO 2017/177181 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 201662319980 P | 2016-04-08 | US | |
| 201762453110 P | 2017-02-01 | US |
| (72) |
GROMADA, Jesper , US
GUSAROVA, Viktoria , US
MURPHY, Andrew J. , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Hiperlipidemijos gydymo būdai ANGPTL8 inhibitoriumi ir ANGPTL3 inhibitoriumi |
| METHODS FOR TREATING HYPERLIPIDEMIA WITH AN ANGPTL8 INHIBITOR AND AN ANGPTL3 INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2022-03-22 | 6 | 139.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2023-04-07 |